Hutch News

Stories tagged 'Paul Nghiem'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 2, 2017

Novel gene therapy for sickle cell disease and related disorders on the horizon; immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care; Dr. Cara McDermott receives AcademyHealth new investigator award; and study documents sperm changes years after chemotherapy.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 19, 2017

Dr. Larry Corey wins $2.6 million grant to explore using CAR T cells for HIV cure; Immune responses against virus-related cancer may provide clues for improved immunotherapy; Hutch/UW symposium underscores Seattle's reputation as "infectious disease central"; Fred Hutch CIO Matthew Trunnell among speakers at SLU Collaborative seminar.

View story >


Looking back at the future

A roundup of some of our favorite 2016 stories on research at Fred Hutch

Dec. 30, 2016 | By Fred Hutch News Service staff

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

View story >


‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies

Dec. 16, 2016 | By Susan Keown / Fred Hutch News Service

Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.

View story >


A new blood test detects recurrence of rare skin cancer

$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging

Dec. 12, 2016 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch and UW researchers have developed an inexpensive blood test to catch recurrences of Merkel cell carcinoma -- in some cases the tests finds tumors earlier than traditional imaging.

View story >


'Finally showing hope'

Immunotherapy trial results transforming care for rare skin cancer

April 19, 2016 | By Susan Keown / Fred Hutch News Service

With few remaining options for treating his aggressive Merkel cell carcinoma, Stan Collender joined a clinical trial of the immune-modulating drug pembrolizumab. The trial's results are giving new hope to people with this rare cancer.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.